A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome
- Author(s)
- Koo, RM; Wong, E; Davis, JE; Perera, T; Lim, A; Koldej, RM; Ritchie, DS;
- Details
- Publication Year 2024,Volume 59,Issue #7,Page 1025-1027
- Journal Title
- Bone Marrow Transplantation
- Publication Type
- Research article
- Publisher
- Springer Nature
- Keywords
- Humans; *Lenalidomide/administration & dosage/therapeutic use; *Leukemia, Myeloid, Acute/therapy; *Myelodysplastic Syndromes/therapy; Male; Female; Middle Aged; *Hematopoietic Stem Cell Transplantation/methods; Adult; Aged; Transplantation, Homologous/methods; Allografts
- Department(s)
- Clinical Haematology
- Publisher's Version
- https://doi.org/10.1038/s41409-023-02195-x
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-08-06 05:34:03
Last Modified: 2024-08-06 05:34:17